Sabra Healthcare REIT (NASDAQ:SBRA) Hits New 12-Month High – What’s Next?

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) hit a new 52-week high during trading on Wednesday . The company traded as high as $21.09 and last traded at $20.8910, with a volume of 105726 shares changing hands. The stock had previously closed at $20.97.

Analysts Set New Price Targets

Several analysts have commented on SBRA shares. Scotiabank lifted their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “sector perform” rating in a research note on Monday, March 2nd. Citigroup raised their target price on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday, February 18th. Wells Fargo & Company boosted their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company an “overweight” rating in a research report on Thursday, March 26th. Wall Street Zen lowered shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Sunday. Finally, UBS Group increased their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Wednesday. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Sabra Healthcare REIT has a consensus rating of “Moderate Buy” and a consensus price target of $22.20.

Sabra Healthcare REIT Stock Up 0.2%

The business’s fifty day simple moving average is $20.25 and its two-hundred day simple moving average is $19.47. The company has a market cap of $5.30 billion, a PE ratio of 33.34, a PEG ratio of 1.65 and a beta of 0.67. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm had revenue of $221.75 million for the quarter, compared to analysts’ expectations of $209.20 million. During the same period last year, the firm earned $0.37 EPS. The company’s quarterly revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, analysts predict that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 29th. Shareholders of record on Friday, May 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 5.7%. The ex-dividend date of this dividend is Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 190.48%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Rothschild Investment LLC increased its holdings in Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 889 shares in the last quarter. Smartleaf Asset Management LLC lifted its holdings in Sabra Healthcare REIT by 97.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 714 shares in the last quarter. Founders Capital Management purchased a new position in Sabra Healthcare REIT during the third quarter valued at $28,000. Strengthening Families & Communities LLC acquired a new stake in shares of Sabra Healthcare REIT in the fourth quarter valued at about $29,000. Finally, Danske Bank A S purchased a new stake in shares of Sabra Healthcare REIT during the third quarter worth about $30,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.